CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023
Cash flows from operating activities:
Net loss	$ (635,586)	$ (453,384)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	85,332	52,447
Non-cash operating lease costs	27,568	25,653
Amortization of deferred commissions	45,586	35,853
Stock-based compensation, net of amounts capitalized	687,936	564,231
Net accretion of discounts on investments	(24,772)	(32,992)
Net realized and unrealized losses (gains) on strategic investments in equity securities	27,203	(2,895)
Deferred income tax	49	(12,894)
Other	1,918	11,812
Changes in operating assets and liabilities, net of effects of business combinations:
Accounts receivable	492,192	309,843
Deferred commissions	(36,754)	(40,992)
Prepaid expenses and other assets	33,347	46,916
Accounts payable	91,425	17,469
Accrued expenses and other liabilities	4,637	27,106
Operating lease liabilities	(25,289)	(16,023)
Deferred revenue	(349,459)	(149,515)
Net cash provided by operating activities	425,333	382,635
Cash flows from investing activities:
Purchases of property and equipment	(21,562)	(13,268)
Capitalized internal-use software development costs	(13,396)	(17,215)
Cash paid for business combinations, net of cash, cash equivalents, and restricted cash acquired	(8,906)	(264,571)
Purchases of intangible assets	0	(27,480)
Purchases of investments	(1,274,742)	(1,725,964)
Sales of investments	40,797	7,266
Maturities and redemptions of investments	1,511,458	1,780,061
Settlement of cash flow hedges	(749)	0
Net cash provided by (used in) investing activities	232,900	(261,171)
Cash flows from financing activities:
Proceeds from exercise of stock options	23,664	31,519
Proceeds from issuance of common stock under employee stock purchase plan	46,735	37,065
Taxes paid related to net share settlement of equity awards	(278,114)	(182,710)
Repurchases of common stock	(916,329)	(191,694)
Net cash used in financing activities	(1,124,044)	(305,820)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(1,909)	1,005
Net decrease in cash, cash equivalents, and restricted cash	(467,720)	(183,351)
Cash, cash equivalents, and restricted cash—beginning of period	1,780,977	956,731
Cash, cash equivalents, and restricted cash—end of period	1,313,257	773,380
Supplemental disclosures of non-cash investing and financing activities:
Property and equipment included in accounts payable and accrued expenses	20,168	6,474
Stock-based compensation included in capitalized software development costs	17,141	24,622
Unpaid taxes related to net share settlement of equity awards included in accrued expenses and other current liabilities	4,719	6,249
Reconciliation of cash, cash equivalents, and restricted cash:
Cash and cash equivalents	1,282,045	755,192
Restricted cash—included in other assets and prepaid expenses and other current assets	31,212	18,188
Total cash, cash equivalents, and restricted cash	$ 1,313,257	$ 773,380